TRT results on TikTok: what bloodwork actually tells you

What did @ecommerce_uk actually say?

The creator shared bloodwork results on their TRT journey and made several specific claims. They said their testosterone level was "a four which was extremely low" before treatment, and that they now sit at 24.5, which they describe as "perfectly in range." They also claimed that doctors require a level "under eight" before they'll prescribe anything, and that they're self-managing their therapy to stay in range rather than chasing high numbers. The caption frames this as informed, monitored treatment, contrasting it with "advice from Dave at the gym."

These are actually fairly specific clinical claims, not just vibes. The numbers they cite map onto nmol/L units, which is the standard measurement used in the UK. That context matters a lot for evaluating whether any of this holds up.

Does the science back this up?

Partly, yes. The claim that 4 nmol/L is extremely low is well-supported. UK and European clinical guidelines consistently define hypogonadism as total testosterone below 8-12 nmol/L depending on the source. The NHS and the British Society for Sexual Medicine (BSSM) use 8 nmol/L as a common threshold for treatment consideration, which aligns with the creator's claim about what doctors require.

The target of 24.5 nmol/L is within the adult male reference range, which most UK labs define as roughly 8-31 nmol/L, with optimal zones typically cited between 15-30 nmol/L. Hackett et al. (2017, International Journal of Clinical Practice) found that maintaining testosterone in the mid-to-upper normal range improved symptoms without significantly increasing adverse events. So landing at 24.5 nmol/L is not reckless. It is a reasonable therapeutic target for someone being monitored.

That said, the creator provides no information about what they're using, how frequently, or whether other markers like haematocrit, PSA, or LH are being tracked. Those omissions matter clinically, even if the numbers quoted are defensible.

What did they get wrong (or right)?

They got the numbers mostly right. A starting testosterone of 4 nmol/L is genuinely low by any clinical standard. The 8 nmol/L threshold claim is a reasonable approximation of NHS prescribing guidelines, though the exact threshold varies by trust and clinical presentation. A post-treatment level of 24.5 nmol/L is within normal adult range and not indicative of abuse or supraphysiological dosing.

Where this gets murky is the phrase "my own therapy." That strongly implies self-administration without a prescribing clinician, which raises monitoring concerns that numbers alone can't resolve. Testosterone therapy without concurrent haematocrit monitoring, for example, carries real cardiovascular risk. Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism) documented dose-dependent increases in red blood cell mass with testosterone treatment. A single total testosterone reading tells you very little without that context.

To their credit, the creator explicitly discourages copying their approach and emphasizes working with "the right people." That disclaimer is genuinely responsible, even if it sits awkwardly alongside the self-directed framing.

What should you actually know?

TRT is a legitimate medical treatment for hypogonadism, and the stigma around it has historically left men symptomatic longer than necessary. The creator is right that dosing is individual and that bloodwork is the foundation of any honest TRT discussion. Those are fair points.

But total testosterone is one data point. A complete TRT panel typically includes free testosterone, sex hormone-binding globulin (SHBG), LH, FSH, haematocrit, PSA (age-dependent), and a liver panel. Morales et al. (2010, European Urology) set out monitoring expectations that cover most of these markers at baseline and follow-up intervals. Skipping them doesn't mean the therapy is failing, but it does mean you're flying with fewer instruments.

Self-managed TRT is not categorically dangerous, but the risk profile changes meaningfully without clinical oversight. If you're in the UK and symptomatic, the BSSM guidelines are publicly available and worth reading before any of that. Bloodwork is not optional, it's the whole ballgame.